XML 47 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation (Tables)
 12 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Compensation Cost Relating to Share-Based Payments The amounts and location of compensation cost relating to share-based payments included in the consolidated statements of income is as follows:
(Millions of dollars)202220212020
Cost of products sold$46 $43 $40 
Selling and administrative expense156 158 150 
Research and development expense37 36 34 
Acquisitions and other restructurings1 1 20 
Total share-based compensation cost$240 $238 $245 
Tax benefit associated with share-based compensation costs recognized$55 $55 $57 
Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods The fair value of awards was estimated on the date of grant using a lattice-based binomial option valuation model and these valuations were largely based upon the following weighted-average assumptions:
202220212020
Risk-free interest rate1.41%0.68%1.69%
Expected volatility22.0%23.0%19.0%
Expected dividend yield1.42%1.46%1.24%
Expected life7.3 years7.4 years7.4 years
Fair value derived$49.45$44.38$48.82
Summary of SARs Outstanding
A summary of SARs outstanding as of September 30, 2022 and changes during the year then ended is as follows:
SARs (in
thousands)		Weighted
Average
Exercise Price		Weighted
Average
Remaining
Contractual Term
(Years)		Aggregate
Intrinsic
Value
(Millions
of dollars)
Balance at October 16,295 $179.64 
Granted909 245.09 
Exercised(1,408)125.57 
Forfeited, canceled or expired(191)234.50 
Awards transferred to Embecta at spin-off (a)(159)239.77 
Adjustments to BD awards related to the spin-off of Embecta (b)97 
Balance at September 305,544 $197.31 5.66$183 
Vested and expected to vest at September 305,377 196.10 5.58$183 
Exercisable at September 303,877 $180.47 4.51$183 
(a)In connection with the spin-off of Embecta, all outstanding (vested and unvested) BD SARs which had been granted to Embecta employees were converted into Embecta awards. These awards preserved the same intrinsic value, as well as general terms and conditions, of the original BD awards.
(b)In connection with the spin-off of Embecta, all outstanding BD awards were adjusted to preserve the aggregate value of the awards as measured immediately prior to the spin-off.
Schedule Of Share Based Compensation, Summary of Stock Appreciation Rights Exercised
A summary of SARs exercised during 2022, 2021 and 2020 is as follows:
(Millions of dollars)202220212020
Total intrinsic value of SARs exercised$184 $102 $212 
Total fair value of SARs vested$36 $39 $46 
Summary of Performance-Based Restricted Stock Units Outstanding
A summary of restricted stock units outstanding as of September 30, 2022 and changes during the year then ended is as follows:
Performance-BasedTime-Vested
Stock Units (in
thousands)		Weighted
Average Grant
Date Fair Value		Stock Units (in
thousands)		Weighted
Average Grant
Date Fair Value
Balance at October 1957 $231.63 1,556 $221.11 
Granted390 242.39 969 239.39 
Distributed(39)237.55 (524)224.81 
Forfeited or canceled(369)235.18 (378)228.88 
Awards transferred to Embecta at spin-off (a)(21)$234.18 (88)$237.60 
Adjustments to BD awards related to the spin-off of Embecta (b)16 27 
Balance at September 30934 (c)$230.46 1,561 $224.87 
Expected to vest at September 30483 (d)$229.32 1,453 $224.31 
(a)In connection with the spin-off of Embecta, all outstanding (vested and unvested) BD restricted stock units which had been granted to Embecta employees were converted into Embecta awards. These awards preserved the same intrinsic value, as well as general terms and conditions, of the original BD awards.
(b)In connection with the spin-off of Embecta, all outstanding BD awards were adjusted to preserve the aggregate value of the awards as measured immediately prior to the spin-off.
(c)Based on 200% of target payout for performance based restricted units and 100% of the performance based time-vested units.
(d)Net of expected forfeited units and units in excess of the expected performance payout of 65 thousand and 386 thousand shares, respectively.
Schedule Of Share Based Compensation, Restricted Stock Units, Grant Date Fair Value of Units Granted
The weighted average grant date fair value of restricted stock units granted during the years 2022, 2021 and 2020 are as follows:
Performance-BasedTime-Vested
202220212020202220212020
Weighted average grant date fair value of units granted$242.39 $216.39 $245.06 $239.39 $223.60 $249.94 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The total fair value of stock units vested during 2022, 2021 and 2020 was as follows:
Performance-BasedTime-Vested
(Millions of dollars)202220212020202220212020
Total fair value of units vested$14 $16 $27 $169 $203 $211